Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

OmniaMed UK appoints new senior management

November 24, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

OmniaMed has strengthened its senior management team by appointing Dr Clive Deverson as managing director and Dr Colin Griffin as …
Appointment
pfizer_logo

Pfizer and Allergan on brink of $150 billion merger

November 23, 2015 Sales and Marketing

Pfizer is reported to have secured formal board approval for a deal worth more than $150 billion to merge with …
News
cosentyx_logo

Novartis bags two EU Cosentyx approvals

November 23, 2015 Research and Development, Sales and Marketing

The European Commission (EC) has approved Novartis’ Cosentyx (secukinumab) for the treatment of people living with ankylosing spondylitis (AS) and …
News
horizon_pharma

Horizon withdraws $1bn Depomed bid

November 20, 2015 Sales and Marketing

Horizon Pharma has withdrawn its $1 billion unsolicited offer for Depomed following a block from a California court based on Horizon’s inappropriate …
News
amgen_flag

European Commission approves Amgen’s cancer drug Kyprolis in combo therapy

November 20, 2015 Research and Development, Sales and Marketing

The European Commission (EC) has today granted marketing authorization for Amgen’s Kyprolis (carfilzomib) in combination with lenalidomide and dexamethasone for …
News
ema_logo

Bioproject’s narcolepsy treatment recommended for European approval

November 20, 2015 Research and Development, Sales and Marketing

The European Medicines Agency (EMA) has recommended granting a marketing authorisation for Bioproject’s Wakix (pitolisant) for the treatment of narcolepsy …
News
ema_inside

Biogen’s Enbrel biosimilar gets positive CHMP opinion

November 20, 2015 Research and Development, Sales and Marketing

The Committee for Medicinal Products for Human Use (CHMP) today gave a positive opinion to Benepali- the first biosimilar version …
News
abpi_logo_on_wall

PMCPA rules on two Bayer conduct breach allegations

November 20, 2015 Medical Communications, Sales and Marketing

The pharma industry regulator in the UK, the PMCPA, has ruled on two alleged breaches of the ABPI code of …
News
Turing logo

Top five pharma controversies of 2015 (so far)

November 20, 2015 Medical Communications, Sales and Marketing AstraZeneca, Martin Shkreli, Philidore, Takeda, Turing Pharmaceutical, Valeant, Warner Chilcott, controversies, fraud, reputation, tax avoidance, turing

5. AstraZeneca forced to deny tax avoidance allegations
Feature
lyrica_advert

American Medical Association calls for ban on drug commercials

November 19, 2015 Medical Communications, Sales and Marketing

The American Medical Association (AMA) has called for a ban on the promotion of prescription products; action which it believes …
News
bayer_cross_2

NICE decision restricts Bayer’s Xofigo to select prostate cancer patients

November 19, 2015 Research and Development, Sales and Marketing Bayer, NICE, prostate cancer

NICE has issued its Final Appraisal Determination (FAD) recommending Bayer’s Xofigo (radium-223 dichloride) for use on the NHS in England …
News
Merck

Merck KGaA completes $17bn Sigma-Aldrich acquisition

November 18, 2015 Manufacturing and Production, Sales and Marketing M&A Sigma Aldridge, Merck, acquisitions, mergers

Merck KGaA has announced the completion of its $17 billion acquisition of Sigma-Aldrich, having cleared the final regulatory hurdle and …
News
US Capitol building

Obama FDA commissioner nominee Califf defends big pharma ties

November 18, 2015 Sales and Marketing Bernie Sanders, FDA, FDA commissioner, Robert Califf

President Obama’s nominee to head the FDA was forced to defend his history of ties to the pharma industry as …
News

NICE rejects Amgen’s Repatha in draft guidance

November 18, 2015 Research and Development, Sales and Marketing Amgen, NICE, Repatha, evolocumab, high cholesterol

NICE has published draft guidance rejecting Amgen’s Repatha as a treatment for people with high cholesterol.   
News
FDA sign

FDA accepts regulatory submission for Novartis biosimilar

November 18, 2015 Research and Development, Sales and Marketing Neulasta, Novartis, Sandoz, biosimilar, pegfilgrastim

Novartis’ generics unit Sandoz has announced it has had its Biologics License Application (BLA) for a proposed biosimilar to Amgen’s …
News
The Gateway to Local Adoption Series

Latest content

Vedana emerges with $46m funding to advance next-generation migraine therapies

June 26, 2026

Phase 1 study supports further development of inhaled respiratory therapy

June 25, 2026

PL BioScience appoints Maik Jornitz to Board of Directors

June 24, 2026

Axplora consolidates liver disease API manufacturing in India

June 23, 2026

Data suggests avapritinib improves quality of life for patients with mastocytosis

June 22, 2026